TechTarsFinancial Intelligence

Navigate

Browse & analyze

Why Nifty, Sensex & S&P moved

SIP, EMI, FD & more

Your saved stocks

Account

Disclaimer: TechTars provides educational analytics and financial tools for informational purposes only. Nothing on this platform constitutes investment advice, financial advice, or trading recommendations. TechTars is not a SEBI-registered investment adviser or research analyst, and no content here is a recommendation to buy, sell, or hold any security. Always consult a qualified, SEBI-registered financial advisor before making investment decisions.

TechTars

Structured financial intelligence.
No tips. No noise. Just data.

Product

Indian Stocks
US Stocks
Market Indices
SIP Calculator
Blog & Guides

Legal

Privacy Policy
Terms of Service
Disclaimer

🔒Your data stays private

© 2026 TechTars.com

Market data delayed by ~15 minutes. Not investment advice.

Home
/
US Stocks
/
Eli Lilly and Company vs AbbVie Inc.

Eli Lilly and Company vs AbbVie Inc.

Side-by-side stock comparison - today's price, technicals, and structured verdict.

More US stock comparisons

→Apple Inc. vs Microsoft Corporation →Microsoft Corporation vs Alphabet Inc.→Alphabet Inc. vs Meta Platforms Inc.→NVIDIA Corporation vs Advanced Micro Devices →Advanced Micro Devices vs Intel Corporation →NVIDIA Corporation vs Intel Corporation

Written by Yadav Patle· Founder, TechTars · 7+ years tracking Indian & US markets

•

Last updated: 8 September 2026 at 9:27 am IST

•How we analyse stocksFounder, TechTars · 7+ years tracking Indian & US markets

Eli Lilly and Company (LLY) is down 0.88% while AbbVie Inc. (ABBV) is down 1.44% on the NYSE/NASDAQ. Today, Eli Lilly and Company is outperforming on a percentage basis.

Eli Lilly and CompanyLLY

$1149.36

-0.88%

VS

AbbVie Inc.ABBV

$256.46

-1.44%

Eli Lilly and Company vs AbbVie Inc.: today's numbers

$1149.36

Price

$256.46

-0.88%

Today

-1.44%

54/100Moderate

TechTars Score

41/100Developing

Bearish

Market bias

Bearish

Bearish

Sentiment

Bearish

41 (neutral)

RSI

50 (neutral)

Uptrend

Trend

Uptrend

-

MACD

-

$1138.68

Support

$254.36

$1174.42

Resistance

$260.97

Medium

Confidence

Medium

Why Eli Lilly and Company moved today

LLY fell 0.88% on continued reaction to GLP-1 weight loss drug commentary, despite sector gains.

Why AbbVie Inc. moved today

ABBV fell 1.4% following reports that abbVie (ABBV) Stock Looks Below Fair Value Despite Mixed Valuation...

Read full Eli Lilly and Company analysis Read full AbbVie Inc. analysis

This side-by-side comparison of LLY and ABBV is generated from publicly available price, volume, and news data using the methodology at /methodology/stock-analysis. It is educational context, not a recommendation to buy or sell either stock, and does not say which is a "better" investment. Prices and indicators change minute-to-minute. Consult a SEBI-registered investment adviser before acting on any of this information.